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Tuberous sclerosis complex proteins
control axon formation
Yong-Jin Choi,1 Alessia Di Nardo,1 Ioannis Kramvis,1 Lynsey Meikle,2 David J. Kwiatkowski,2
Mustafa Sahin,1,4 and Xi He1,3
1The F.M. Kirby Neurobiology Center, Department of Neurology, Children’s Hospital Boston, Harvard Medical School,
Boston, Massachusetts 02115, USA; 2Division of Translational Medicine, Department of Medicine, Brigham and Women’s
Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Axon formation is fundamental for brain development and function. TSC1 and TSC2 are two genes, mutations
in which cause tuberous sclerosis complex (TSC), a disease characterized by tumor predisposition and
neurological abnormalities including epilepsy, mental retardation, and autism. Here we show that Tsc1 and
Tsc2 have critical functions in mammalian axon formation and growth. Overexpression of Tsc1/Tsc2
suppresses axon formation, whereas a lack of Tsc1 or Tsc2 function induces ectopic axons in vitro and in the
mouse brain. Tsc2 is phosphorylated and inhibited in the axon but not dendrites. Inactivation of Tsc1/Tsc2
promotes axonal growth, at least in part, via up-regulation of neuronal polarity SAD kinase, which is also
elevated in cortical tubers of a TSC patient. Our results reveal key roles of TSC1/TSC2 in neuronal polarity,
suggest a common pathway regulating polarization/growth in neurons and cell size in other tissues, and have
implications for the understanding of the pathogenesis of TSC and associated neurological disorders and for
axonal regeneration.
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Neuronal polarity, as defined by the elaboration of a
single axon and multiple dendrites, is fundamental for
brain development and function (Craig and Banker 1994;
Arimura and Kaibuchi 2007). The axon and dendrites
exhibit distinct cell biological compositions and func-
tionality, and constitute the cellular basis for directional
information flow within the nervous system (Craig and
Banker 1994). Neuronal polarity has been studied using
dissociated rat embryonic hippocampal neurons, which
undergo characteristic growth stages in culture (Dotti et
al. 1988; Craig and Banker 1994). These neurons initially
form multiple lamellipodia after plating and generate
minor neurites with similar lengths (stage 1–2); one of
these neurites subsequently grows extensively to form
an axon (stage 3), whereas the remaining neurites initiate
subsequent growth and mature into dendrites (stage 4–5).
This process appears to involve the initial axon fate de-
termination coupled with polarized axonal growth and is
reinforced by positive and negative feedback loops such
that only a single axon is elaborated (Shi et al. 2003;
Arimura and Kaibuchi 2007; Barnes et al. 2008). Many
molecules have been identified to have a role in hippo-
campal neuronal polarity in vitro (Shi et al. 2003; Me-
nager et al. 2004; Nishimura et al. 2004; Schwamborn
and Puschel 2004; Chen et al. 2006; Jacobson et al. 2006;
Barnes et al. 2007). Of these, however, only LKB1 and
SAD-A and SAD-B kinases have been shown to exert
functions in neuronal polarity in vivo (Kishi et al. 2005;
Barnes et al. 2007; Shelly et al. 2007).
Tuberous sclerosis complex (TSC) is an autosomal
dominant hamartoma syndrome, which is characterized
by dysplastic and disorganized overgrowth within many
organs and is caused by loss-of-function mutations in
TSC1 or TSC2 (Kwiatkowski and Manning 2005; Crino
et al. 2006). TSC1 and TSC2 play central roles in restrict-
ing cell growth/size and therefore in tumor suppression
(Tee et al. 2002; Inoki et al. 2003; Kwiatkowski and Man-
ning 2005). TSC2 encodes a GTPase activating protein
(GAP) for the Rheb GTPase, which is an activator for the
mammalian TOR (target of rapamycin) kinase. mTOR in
turn phosphorylates the ribosomal S6 kinase (S6K) and
the translational regulator 4E-BP1, thereby stimulating
the synthesis of selected proteins that promote cell
growth (Wullschleger et al. 2006). The TSC1/TSC2 pro-
tein complex is obligatory for TSC2 GAP function, and
together they inhibit mTOR signaling (Inoki et al. 2003;
Stocker et al. 2003; Tee et al. 2003; Zhang et al. 2003).
Growth factors stimulate cell growth/size through TSC2
phosphorylation and inactivation via the PI3 kinase
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(PI3K) and the Akt kinase pathway (Inoki et al. 2002;
Manning et al. 2002; Potter et al. 2002). In addition to
hamartomas, most TSC patients exhibit neurological
disorders including epilepsy, mental retardation, and au-
tism, but the underlying pathological basis remains
poorly defined. Here we show that TSC1 and TSC2 have
critical negative roles in mammalian axon formation in
vitro and in vivo.
Results
Tsc pathway components are expressed in neurons
in a polarized manner
PI3K/Akt signaling in the axon may play a role in neu-
ronal polarization in vitro (Shi et al. 2003; Jiang et al.
2005). Although Akt phosphorylates numerous targets,
we considered the possibility that Akt may phosphory-
late and inhibit TSC2 as observed in nonneuronal cells
(Inoki et al. 2002; Manning et al. 2002; Potter et al. 2002).
We first confirmed that in stage 3 hippocampal neurons
in culture, the activated Akt (phospho-Akt, Ser473) was
enriched in the axon as described (Fig. 1A,B; Shi et al.
2003). Although Tsc1 and Tsc2 are localized in growth
cones of cortical neurons in culture (Haddad et al. 2002),
we found that, interestingly, the phosphorylated (at
Thr1462) and thus inactivated Tsc2 was specifically lo-
calized along the axon (Fig. 1C,D), while total Tsc2 was
evenly distributed throughout the neuron (Fig. 1E,F;
Supplemental Fig. 1B). A PI3K inhibitor, LY294002,
which blocks Akt activation and thus Tsc2 phosphory-
lation (Inoki et al. 2002), significantly reduced phospho-
Tsc2 staining (Supplemental Fig. 1A), implying that Tsc2
phosphorylation/inactivation in the axon is mediated by
the PI3K/Akt pathway. Importantly, in mouse brain
slices from embryonic day 19 (E19), the phospho-Tsc2
antibody exhibited indistinguishable staining from that
of an axon-specific marker (SMI-312) in the axon-rich
intermediate zone (Fig. 1I, arrows). We also found that
phospho-S6K (Thr389), a downstream target of TSC/
mTOR signaling, was enriched in the axon but not in
dendrites (Fig. 1G,H). Inhibition of mTOR via rapamycin
markedly reduced the phospho-S6K staining in the axon
(Supplemental Fig. 1C). These results suggest that inac-
tivation of Tsc2 and activation of the mTOR pathway
occur specifically in the axon in polarized neurons.
Figure 1. Polarized activation/inactivation of Tsc
pathway components in the axon versus dendrites.
Axon-specific localization of active (phosphorylated)
Akt, inactive (phosphorylated) Tsc2 and active
(phosphorylated) S6K (A,C,G) and the profiles of
their fluorescence intensity (B,D,H) in the axon and
dendrites of stage 3 hippocampal neurons. Fixed
neurons were costained with Tau1 (axon-specific
marker) or Tuj1 (labeling both axon and dendrites).
Each immunostaining was performed in at least four
independent experiments, and the images shown are
representative of more than 50 neurons examined.
(A,B) Phospho-Akt (S473) signal is enriched in the
axon. (C,D) Phospho-Tsc2 (T1462) signal is only de-
tected in the axon (arrow), but not in dendrites (ar-
rowheads). (E,F) The level of Tsc2 is approximately
the same in the axon and in dendrites. (G,H) Phos-
pho-S6K (T389) is enriched in the axon compared
with the shorter dendrites. Bars, 10 µm. (I) Phospho-
Tsc2 staining is indistinguishable from axonal
marker SMI-312 in the E19 cortical slice. Arrow in-
dicates the main axon tracks positive for phospho-
Tsc2. Bar, 100 µm.
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We further examined the localization of phospho-Tsc2
in earlier stages (stages 1–2) before and at the onset of
neuronal polarization. At stage 1, phospho-Tsc2 was
found to be concentrated in the cytoplasm in a punctuate
manner and in lamellipodia (Supplemental Fig. 2). At
stage 2, phospho-Tsc2 staining was prominent in the
growth cone and the shaft of multiple neurites in the
majority (69.6%) of neurons, or, in contrast, was re-
stricted to the growth cone and the shaft of a single neu-
rite in the remaining (30.4%) neurons (Supplemental Fig.
2). These two distinct patterns of phospho-Tsc2 at this
early stage may reflect the polarization process by which
a single neurite is selected to become the axon.
The effect of Tsc overexpression and Tsc deficiency
on axon formation
We asked whether increasing Tsc1/Tsc2 expression
would suppress axon specification and growth. Since
Tsc1 and Tsc2 function as a heterodimeric complex, we
coexpressed Tsc1 plus Tsc2 in hippocampal neurons.
Tsc1/Tsc2 coexpression resulted in fewer neurons pos-
sessing an axon (59.2% of neurons, compared with
87.8% of neurons expressing EGFP) (Fig. 2A,B). Further-
more, 34.8% of neurons displayed no axons compared
with 8.2% of neurons expressing EGFP (Fig. 2A,B). These
results indicate that an increase in Tsc1/Tsc2 level in-
hibits axon growth.
We then examined the effect of loss of Tsc1/Tsc2 on
axon specification and growth in hippocampal neurons.
We first studied the effect of Tsc2 knockdown using
three different shRNA constructs that can each target
both rat and mouse Tsc2 (Tsc2/sh1, Tsc2/sh2, and Tsc2/
sh3). These shRNAs significantly knocked down the ex-
pression of epitope-tagged and the endogenous Tsc2 in
HEK293T cells and primary rat hippocampal neurons,
respectively (Fig. 3A; Supplemental Fig. 3), and strik-
ingly, resulted in an increase in neurons displaying mul-
tiple axons (from 9.6% to 43.6%) that were positive for
the axon-specific marker Tau1 (Fig. 3B).
We also generated Tsc1−/− neurons via expressing Cre
recombinase in cultured E17 hippocampal neurons iso-
lated from Tsc1 conditional knockout mice (Tsc1flox/flox)
(Meikle et al. 2005, 2007). Cre effectively deleted the
Tsc1 gene, as demonstrated by the reduced Tsc1 protein
level (Fig. 3C). Tsc1 deletion also increased the number
of neurons having multiple axons (from 4.3% to 45.8%)
(Fig. 3D). Neither the control EGFP (enhanced green
fluorescence protein) expression in the Tsc1flox/flox
neurons (Fig. 3D) nor the Cre expression in the wild-
type neurons (Supplemental Fig. 4) generated multiple
axons. There was no statistically significant difference
between Tsc1−/− neurons and control neurons in terms of
axonal and dendritic length (Supplemental Fig. 5). The
indistinguishable effect of Tsc2 knockdown compared
with Tsc1 deletion is consistent with Tsc1/Tsc2 func-
tioning in a complex. These findings suggest that the
Tsc1/Tsc2 protein complex restricts axon formation and
growth.
Tsc1/Tsc2 acts upstream of mTOR-mediated axonal
growth regulatory pathway
mTOR resides in two distinct multiprotein complexes
called mTORC1 and mTORC2 (Sarbassov et al. 2005).
mTORC1 is sensitive to rapamycin and controls cell
growth through S6K and 4E-BP1, whereas mTORC2 is
rapamycin-insensitive and regulates the actin cytoskel-
eton. We found that rapamycin prevented axonal growth
but not dendritic growth in the wild-type hippocampal
neurons (Fig. 4A). Furthermore, rapamycin treatment of
Tsc2-deficient neurons not only decreased the number of
neurons having multiple axons (from 54.7% to 13.5%),
but also increased the number of neurons without an
axon (from 10.3% to 64.4%) (Fig. 4A,B). Therefore, Tsc1/
Tsc2 controls axon formation via the mTORC1 path-
way, consistent with phospho-S6K being enriched in the
axon shaft (Fig. 1G,H).
Figure 2. Tsc overexpression suppresses axon specification/
growth in culture. (A,B) Suppression of axon formation by Tsc1
plus Tsc2 overexpression. (A) Representative hippocampal neu-
rons transfected with EGFP alone or together with Tsc1/Tsc2.
Neurons were fixed at 6DIV and stained with Tau1 (green,
axonal marker) and MAP2 (red, dendritic marker). EGFP-ex-
pressing control cells show a single axon and multiple den-
drites. Tsc1/Tsc2-expressing cells do not have a Tau1-positive
process. (B) Neuronal polarity phenotypes were categorized into
three groups: no axon (yellow bar), single axon (green bar), and
multiple axons (red bar). (*) P < 0.0005 for single axon between
the two groups by ANOVA. The data represent the mean ± SD
of 74–171 neurons per condition from three independent experi-
ments. Bar, 20 µm.
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Tsc1 deficiency disrupts cortical neuronal morphology
in vivo
We next asked whether a lack of Tsc function affects
axon formation in vivo. We analyzed the brains of Syn-
Cre;Tsc1flox/flox mice (Meikle et al. 2007), in which Cre
expression driven by the Synapsin-1 promoter results in
deletion of the floxed Tsc1 alleles in post-mitotic neu-
rons starting at E13 (Zhu et al. 2001). These Tsc1 mutant
mice exhibit relatively normal cortical and hippocampal
architecture, but develop neurological symptoms includ-
ing seizures starting at postnatal day 5 (P5) and die be-
tween 3 and 5 wk after birth (Meikle et al. 2007). We
analyzed Tsc1−/− mutant cortices at P11 using two axo-
nal markers (SMI-31 and SMI-312) (Xiao and Monteiro
1994; Shelly et al. 2007), together with a phospho-S6 an-
tibody to mark cells exhibiting elevated mTOR signaling
due to Tsc1 deletion (Fig. 5A). Both SMI-31 and SMI-312
staining was highly enriched in the axon-rich interme-
diate zone (Fig. 5A, arrowheads) in the control brain (Fig.
5A). Strikingly, however, Tsc1−/− cortices exhibited ec-
topic SMI-31- and SMI-312-positive axons throughout
the cortex, including the upper cortical plate, which is
normally rich in dendrites (Fig. 5A). These results sug-
gest that a lack of Tsc1 function causes ectopic axon
formation in the brain.
To further examine the role of Tsc1/2 proteins in neu-
ronal morphogenesis at a single neuron resolution, we
introduced either a control shRNA or a Tsc2 shRNA
together with EGFP into the cortical progenitors in E14–
E15 mouse embryos via electroporation as described
(Barnes et al. 2007). Following electroporation, brain
slices were prepared and incubated organotypically on
tissue culture inserts for 3 d to allow enough time for the
progenitors to differentiate and to migrate into the cor-
tical plate. The neurons electroporated with the control
shRNA showed typical morphology of migratory neu-
rons, with 84% of the neurons exhibiting a thick apical
leading process pointing toward pia and a slender trailing
process (Fig. 5B,C; Noctor et al. 2004; Barnes et al. 2007).
In contrast, 45% of the neurons electroporated with Tsc2
shRNA displayed multiple processes oriented either lat-
erally or basally (Fig. 5B,C), and exhibited retarded mi-
gration as reported in neurons with ectopic axon forma-
tion (Shelly et al. 2007). These data, together with the
Tsc1 mutant phenotypes, suggest that Tsc/mTOR sig-
naling is important for establishing neuronal polarity in
vivo.
Tsc regulates the protein level of SAD kinases
in neurons
In nonneuronal cells, the TSC–mTOR pathway controls
cell size in part by selective translational regulation
(Wullschleger et al. 2006). We did not observe general
protein level changes between the wild-type and Tsc1/
2-deficient hippocampal neurons (Fig. 6A; Supplemental
Figure 3. TSC deficiency induces mul-
tiple axons in culture. (A–D) Knockdown
of Tsc2 by shRNA or knockout of Tsc1
induced multiple axons in vitro. (A) Tsc2
protein level in E18 rat hippocampal neu-
rons infected with a lentivirus expressing
control shRNA or shRNA against Tsc2
(shTsc2). (B) E18 rat hippocampal neurons
transfected with either EGFP alone or
EGFP together with Tsc2 shRNA. Tsc2
knockdown induced multiple axons, all of
which are positive for Tau1. (*) P < 0.001
for multiple axons between the two groups
by ANOVA. (C) Tsc1 protein level in E17
Tsc1flox/flox mouse hippocampal neurons
infected with a control or Cre-expressing
lentivirus. Neurons were lysed for West-
ern blot analysis at 6DIV. (D) E17 mouse
hippocampal neurons from Tsc1flox/flox
embryos transfected with EGFP alone or
EGFP together with Cre. Arrowheads
indicate axons positive for Tau1. (*)
P < 0.001 for multiple axons between the
two groups by ANOVA. The data repre-
sent the mean ± SD of 135–185 neurons
per condition from three independent ex-
periments. Bars, 20 µm.
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Fig. 6). We searched for proteins that were regulated by
Tsc1/2 during axon growth by focusing on molecules
that have been implicated in neuronal polarity. Intrigu-
ingly, we found that Tsc2 knockdown specifically in-
creased the protein level of the SAD kinase (Fig. 6A).
SAD-A together with the related SAD-B have been
shown to be critical for axon formation in the mouse
brain (Kishi et al. 2005). The increase in SAD-A level by
Tsc2 knockdown was dependent on mTORC1 activation
and was prevented by rapamycin, which, of note, did not
affect the basal SAD-A level (Fig. 6B). An elevated
SAD-A protein level was also observed in Tsc1−/− hippo-
campal and cortical neurons generated from Tsc1flox/flox
neurons expressing Cre (Fig. 6C). The increase in SAD-A
protein amount in TSC1/2-deficient neurons was likely
due to enhanced protein synthesis, because the SAD-A
mRNA level was not altered upon Tsc2 knockdown
(Supplemental Fig. 7A), and the SAD-A protein level was
not affected when proteasome-dependent protein degra-
dation was blocked in either the wild-type or the Tsc2-
deficient neurons (Supplemental Fig. 7B). We found that
the SAD-B protein level was also elevated in Tsc1−/− cor-
tical neurons (Supplemental Fig. 7C).
A vast majority of TSC patients exhibit neurological
abnormalities (Crino et al. 2006) and harbor cortical tu-
bers with characteristic “giant cells” that display high
mTORC1 signaling and are readily identified by their
elevated phospho-S6 levels (Baybis et al. 2004). We ex-
amined whether the SAD-A protein level is increased in
cortical tubers resected from a TSC patient during epi-
lepsy surgery. Phospho-S6-positive giant cells in the cor-
tical tuber examined indeed displayed high SAD-A im-
munoreactivity, while the intensity of a control protein
(-tubulin) in those cells remained unchanged (Fig. 6E).
These giant cells were also positive for neuronal marker
MAP2 and NF (neurofilament), revealing their neuronal
origin (Fig. 6E). We quantified sections double-stained
with phospho-S6 and SAD-A and found that 60% of
phospho-S6-positive cells had increased SAD-A protein.
Taken together, the data produced in Tsc-deficient rat
and mouse neurons as well as human cortical tubers
demonstrate that loss of TSC function leads to increased
SAD kinase protein expression.
It has been shown recently that LKB1 phosphorylates
and activates SAD kinases, resulting in elevated Tau
phosphorylation (at S262) (Barnes et al. 2007). We found
that Tsc1−/− neurons exhibited increased levels of both
phospho-SAD and phospho-Tau (S262) (Fig. 6D), suggest-
ing that the elevated SAD protein level resulting from
Tsc1 deficiency is accompanied by increased SAD kinase
activity.
SAD kinases are required for Tsc regulation of axon
formation
We examined the role of SAD kinases in Tsc1/2-regu-
lated axon growth. As SAD-A and SAD-B share signifi-
cantly redundant roles (Kishi et al. 2005; Barnes et al.
2007), we used shRNAs that knocked down SAD-A and
SAD-B, respectively, which were either expressed ectop-
ically in HEK293T cells (Supplemental Fig. 8) or endog-
enously in hippocampal neurons (Supplemental Fig. 8).
We found that knocking down SAD-A and SAD-B not
only diminished axonal growth in wild-type neurons
(Fig. 7A), but also inhibited the formation of multiple
axons in Tsc2-deficient neurons (Fig. 7A). This inhibi-
tion was incomplete possibly due to residual SAD pro-
teins or the existence of other potential targets regulated
by Tsc1/Tsc2. These results, together with the finding of
Tsc regulation of SAD-A and SAD-B synthesis, suggest
that SAD kinases are important mediators of Tsc1/2
function in axon formation.
We also asked whether an increase in the SAD-A level
could be sufficient for axon formation. SAD-A overex-
pression in hippocampal neurons resulted in two distinct
phenotypes, as neurons with multiple axons (from
13.3% to 32.9%) and those without an axon (from 5.5%
to 24%) were both increased in number (Fig. 7B). For
neurons with multiple axons due to SAD-A overexpres-
sion, we did not observe significant changes in either
axonal or dendritic length compared with control neu-
rons expressing EGFP (Supplemental Fig. 9). We note
that suppression of axon formation in some neurons by
Figure 4. mTOR acts downstream from Tsc2 in neuronal po-
larity. (A) Rapamycin (20 nM) inhibited axon formation/growth
in both the wild-type (WT) and the Tsc2-knockdown rat hippo-
campal neurons. Bar, 20 µm. (B) Quantification of polarity de-
fects. (*) P < 0.01 between multiple axons in shTsc2(+DMSO)
and shTsc2(+Rapa) groups by ANOVA. The data represent the
mean ± SD of 127–180 neurons per condition from three inde-
pendent experiments.
TSC proteins in neuronal polarity
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SAD-A overexpression is not entirely surprising and is
reminiscent of similar observations previously made by
overexpression of other polarity proteins such as Par6
(Shi et al. 2003; Nishimura et al. 2005), and may imply
that SAD kinases function in concert with other mol-
ecules to promote axonal polarity.
Discussion
In this study, we provide evidence that the Tsc1/2 pro-
tein complex is required for neuronal polarity/axon for-
mation. We find that cortical and hippocampal neurons
deficient for Tsc1/2 function form ectopic axons both in
vitro and in vivo. We further identify neuronal polarity
SAD kinases, particularly SAD-A, as target proteins, the
synthesis of which is regulated by Tsc1/2 in neurons.
Thus loss of Tsc function is associated with an increase
in SAD kinase protein levels in rodent neuronal cultures
and in cortical tubers from a TSC patient. In addition, we
find that suppressing SAD expression partially rescues
the multipolar neuronal phenotype in Tsc1/2-deficient
neurons. Thus, the Tsc/mTOR pathway appears to limit
multiple axon formation and acts to confine polarized
growth within a single axon in the mammalian brain,
and its deregulation likely contributes to the neurologi-
cal symptoms commonly observed in TSC patients.
Axon formation in the brain is governed by extracel-
lular signals and the intrinsic polarization apparatus
(Arimura and Kaibuchi 2007; Barnes et al. 2008). Tsc1/
Tsc2 is ideally suited to couple extracellular signals to
the intracellular growth machinery (Wullschleger et al.
2006). We observed that Tsc2 is phosphorylated, and
thus inhibited, and the mTORC1 pathway is activated in
the axon. Inactivation of Tsc1/Tsc2 allows the prospec-
tive axon to initiate and maintain its growth through
mTORC1, while Tsc1/Tsc2 keeps the growth of the re-
maining neurites/dendrites on hold. Growth factors such
as IGF-1 (insulin-like growth factor-1) and BDNF (brain
derived growth factor) (Yoshimura et al. 2005; Sosa et al.
2006; Shelly et al. 2007) activate PI3K and Akt, which
phosphorylate and inactivate Tsc2 (Inoki et al. 2002;
Manning et al. 2002; Potter et al. 2002). Furthermore,
Wnt inhibition of GSK3, which phosphorylates and ac-
tivates Tsc2, also leads to Tsc2 inactivation (Inoki et al.
2006). Thus Tsc2 regulation may mediate the capability
of IGF, BDNF, and Wnt in specifying neuronal polarity
and axonal morphogenesis (Hilliard and Bargmann 2006;
Sosa et al. 2006; Shelly et al. 2007). We note that it has
been suggested that Akt promotes axon formation by
phosphorylation and inhibition of GSK3 (Jiang et al.
2005; Yoshimura et al. 2005). However, mice harboring
GSK3 knockin alleles that abolish the Akt phosphoryla-
tion site are viable and fertile, and cortical and hippo-
campal neurons of these mice are polarized normally in
vitro and in vivo (McManus et al. 2005; Gartner et al.
2006). These and our results together suggest that Akt
phosphorylation of Tsc2, but not GSK3, likely plays a
critical role in neuronal polarity/axonal growth.
While phosphorylation and inactivation of Tsc2 is ob-
served in the axon in polarized neurons, at early stages
(or the onset) of neuronal polarization, phosphorylated
Tsc2 (Thr1462) is observed in the growth cone and shaft
of multiple neurites in a majority (70%) of neurons, and
interestingly, also in the growth cone and shaft of only a
single neurite in the remaining (30%) neurons. We inter-
pret these two distinct patterns of phosphorylated Tsc2
Figure 5. Ectopic axon formation in Syn-
Cre;Tsc1flox/flox mouse cortex and defective
neuronal polarization by Tsc2 knockdown in
organotypic brain slices. (A) Control (left) and
Tsc1−/− (right) cortical sections stained with
phospho-S6 (green) and two axonal markers,
SMI-31 or SMI-312 (red). Nuclei were stained
by Hoechst (blue). In control mice (Syn-
cre;Tsc1flox/+), both SMI-31 and SMI-312
staining was concentrated in the axon-rich in-
termediate zone (IZ, arrowheads), but in
Tsc1−/− mutant mice, SMI-31- and SMI-312-
positive processes were found throughout the
cortex. Bars, 100 µm. (B) EGFP-positive
mouse cortical neurons that express a control
shRNA or Tsc2 shRNA and undergo radial
migration in the intermediate zone. Com-
puter-aided reconstruction/tracing of these
neurons is shown below. E14–E15 mouse em-
bryos were electroporated ex vivo with the
shRNA constructs. Organotypic brain slices
were cultured for 3 d in vitro. In contrast to
the control neurons displaying a thick apical process pointing toward the pia, neurons electroporated with Tsc2 shRNA showed
multiple processes oriented toward the lateral or basal direction. Bar, 50 µm. (C) Quantification of polarity defects in migrating cortical
neurons in the intermediate zone. Phenotypes were categorized into three groups based on the orientation of the apical process: apical
orientation within 15 degrees (green), lateral orientation between 15° and 90° (yellow), and basal orientation with >90° (red).
(*) P < 0.0001 by 2 test. The data represent the mean of 79–83 neurons per condition from three separate experiments.
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as a reflection of neurons in the polarization process
through which a single neurite is selected to become the
axon. While deletion or knockdown of Tsc1/2 is suffi-
cient to initiate and maintain multiple axon formation,
transient phosphorylation/inhibition of Tsc2, as ob-
served in multiple neurites in stage 2 neurons, does not
lead to supernumeric axons. It seems likely that persis-
tent and prolonged phosphorylation/inhibition of Tsc2
in a single neurite, as a result of positive and negative
feedback mechanisms (Shi et al. 2003; Arimura and Kai-
buchi 2007; Barnes et al. 2008), leads to axon specifica-
tion and growth. Given the critical role of Tsc/mTOR
signaling in regulation of protein synthesis, persistent
phosphorylation/inhibition of Tsc2 and activation of
mTOR may result in accumulation of key proteins such
as SAD kinases (see below) for axonogenesis. The mecha-
nisms by which phosphorylated/inactivated Tsc2 is re-
stricted from multiple neurites to a single neurite (the
future axon) and is maintained in the axon deserve fur-
ther investigation.
What downstream effectors are regulated by Tsc/
mTOR signaling during neuronal polarization? In our
study, we found that the synthesis of SAD proteins is
specifically up-regulated by the inactivation of Tsc and
the activation of mTOR signaling. SAD kinases have
been shown as important regulators of neuronal polarity
both in vitro and in vivo (Kishi et al. 2005). Recently,
LKB1 was identified as a critical upstream kinase and
activator for SAD kinases, suggesting a kinase cascade
for axon formation (Barnes et al. 2007). We found that in
Tsc1−/− neurons, the elevated SAD protein amount is
accompanied by elevated levels of phosphorylated SAD
Figure 6. The SAD-A kinase protein level is
regulated by Tsc1/Tsc2 in hippocampal and cor-
tical neurons and in cortical tubers of a TSC pa-
tient. (A) Rat hippocampal neurons infected with
a lentivirus expressing EGFP (LV-EGFP) or an
shRNA against Tsc2 (LV-shTsc2). Neurons were
lysed at 6DIV for Western blot analysis. Tsc2
knockdown increased the levels of phospho-S6
and the SAD-A protein level. (B) Increase in
SAD-A protein level upon Tsc2-knockdown was
blocked by rapamycin treatment. Neurons were
infected with a control lentivirus (LV-EGFP and
LV-GL3, shRNA against luciferase) or LV-
shTsc2. Cells were treated with either DMSO or
rapamycin (20 nM), and lysates were made at
6DIV for Western blot analysis. Note that the
basal level of SAD-A protein was not affected
by rapamycin. (C) The SAD-A protein level was
increased upon deletion of the conditional
Tsc1flox/flox alleles in vitro. E17 Tsc1flox/flox hip-
pocampal and cortical neurons were transduced
with a lentivirus expressing EGFP or Cre. Note
that Tsc1 knockout also markedly reduced the
level of Tsc2 protein as reported and increased
phospho-S6 (pS6). (D) Deletion of Tsc1flox/flox al-
leles in cultured neurons resulted in increased
levels of phospho-SAD and phospho-Tau (S262).
Phospho-SAD was detected using the pSAD(T-al)
antibody, which recognizes both phospho-
SAD-A and -B. (E) Immunohistochemical analy-
sis of SAD-A expression in human tubers from a
TSC patient. Representative images of resected
brain sections show colocalization of (green)
phospho-S6 (pS6) and (red) SAD-A in the giant
cells of the tuber lesion. Positive SAD-A staining
was identified in 60% of the pS6-positive giant
cells (counted 79/131). The giant cells expressing
a high level of SAD-A protein were also positive
for neuronal marker MAP2. (Red) Neurofilament
staining (NF) confirms increased mTOR activity
in the enlarged pS6-positive dysmorphic cells
as described (Ozcan et al. 2008). The staining of
control protein -tubulin showed no changes in
immunoreactivity in pS6-positive cells. Hoechst
dye staining for DNA is shown in blue. Bars,
50 µm.
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and phosphorylated Tau, which is a SAD substrate (Kishi
et al. 2005). These results demonstrate increased SAD
activity and imply that LKB1 and/or other kinases that
phosphorylate SAD proteins are active in these neurons.
Concerted control of the SAD protein amount and activ-
ity by Tsc1/Tsc2 and LKB1 (and/or other kinases), re-
spectively, may be pivotal for the integration of axon
specification and growth. We note that in cancer cells,
LKB1 can activate Tsc1/Tsc2 via the AMPK kinase un-
der energy stress conditions (Shaw et al. 2004a,b). How-
ever, in axonogenesis, Tsc1/2 and LKB1 deficiencies
have opposite effects. Loss of Tsc1/2 results in neurons
with multiple axons, while loss of LKB1 results in neu-
rons with no axons. Therefore, LKB1 activation of
Tsc1/2 is unlikely to be involved in regulating axonal
growth. Although we identified SAD proteins as targets
of Tsc/mTOR signaling, the fact that SAD-A/B knock-
down only partially rescues the multiaxon phenotype
implies that there are likely other downstream targets
yet to be identified. Future studies will shed light on
novel mechanisms regulated by the Tsc/mTOR pathway
during axon formation and expand our understanding of
the various causes of clinical manifestations of TSC in
the brain and other organs. In addition, our study sug-
gests that manipulating the TSC pathway may have
therapeutic applications to axonal repair/regeneration af-
ter neuronal injuries.
Materials and methods
Primary neuronal culture and transfection
Hippocampal cells were prepared according to published proto-
cols (Sahin et al. 2005). Briefly, hippocampi isolated from either
rat (E18) or mouse (E17) were digested with papain for 10 min at
37°C in Hank’s balanced salt solution buffered with HEPES.
Cells were dissociated in plating medium (Neurobasal medium
supplemented with B27) by trituration with a pipette. Neurons
were transfected immediately after dissociation using Amaxa
Nucleofactor (Amaxa Biosystems) and plated on the chamber
slides. Transfected neurons were plated on the Lab-Tek II cham-
ber slides (Nunc) coated with poly-D-Lysine (1 mg/mL; Sigma)
at a density of 1000 cells per well (1.7 cm2). After cells attach to
the slides, medium was replaced with fresh plating medium to
remove unattached cells.
Figure 7. Effects of SAD-A/B knockdown on
axon specification/growth in vitro. (A) Rat
hippocampal neurons were transfected with
control shRNA, SAD-A and SAD-B shRNAs
(shSAD-A/B), Tsc2 shRNA (shTsc2), and sh-
Tsc2 together with shSAD-A/B, and stained
with MAP2 (dendritic marker) and SMI-312
(axonal marker). Knockdown of SAD-A/B
blocked the multiple-axon phenotype in-
duced by the Tsc2 shRNA. Quantification is
shown on the right. (*) P = 0.001 for multiple
axons between the shTsc2 and
shTsc2 + shSAD-A/B groups by ANOVA. (B)
Effects of SAD-A overexpression on neuronal
polarity. Rat hippocampal neurons expressing
EGFP alone or expressing EGFP together with
SAD-A were fixed at 6DIV. SAD-A overex-
pression induced multiple axons in some neu-
rons and inhibited axon formation in others.
Quantification is shown on the right. (*)
P < 0.05 for multiple axons between the two
groups by ANOVA. Bars, 20 µm. The data rep-
resent the mean ± SD of 123–142 neurons per
condition from three independent experi-
ments.
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Ex vivo electroporation and organotypic slice culture
Two to three microliters of DNA constructs (2 µg/µL) together
with EGFP plasmid (2:1 ratio) was injected into the lateral ven-
tricle of each harvested mouse embryo (E14–E15) using a mi-
croinjector (PLI-100; Medical Systems Corp). Fastgreen (0.3 mg/
mL) was added to the DNA solution to monitor the location and
the amount of injection. The head of each injected embryo was
electroporated (four 100-msec pulses, 40 V, 100-msec interval)
using Tweezertrode (Harvard Apparatus) coupled with an elec-
troporator (ECM 830, BTX). Electroporated brains were dis-
sected out and embedded in the 3% low-melting agarose at
∼38°C. Upon solidification on ice, 250-µm coronal brain sec-
tions were made by vibratome (Leica VT100S), and the slices
were transferred onto the tissue culture inserts (Millicell; Mil-
lipore) bathing on culture medium (Neurobasal medium with
B27, N2, L-glutamine, and penicillin and streptomycin) in six-
well plates. After washing with culture medium, slices were
incubated organotypically on the inserts for 3 d. All procedures
were carried out in accordance with the Guide for the Humane
Use and Care of Laboratory Animals, and the study was ap-
proved by the Animal Care and Use Committee of Children’s
Hospital Boston.
Quantification of morphology defects in migrating cortical
neurons
The morphology of individual migrating cortical neurons in the
intermediate zone was categorized into three groups based on
the orientation of their processes. An apical process oriented
within 15° from a line orthogonal to the pial surface was con-
sidered normal. A process oriented more than 15° was grouped
into either lateral or basal. A 2 test was used for the statistical
analysis.
DNA constructs
pcDNA3-Tsc1 and Tsc2 constructs were generously provided
by K.-L. Guan (Inoki et al. 2002). SAD-A and SAD-B constructs
were generously provided by J. Sanes (Kishi et al. 2005). Lenti-
viral vectors were gifts from R. Mulligan (Mostoslavsky et al.
2005). To generate lentiviral Cre constructs, the Cre cDNA was
amplified with a nuclear localization signal using PCR, and
then cloned into lentiviral vectors. The lentiviral Tsc2 shRNA
construct was custom made by Cellogenetics. The target se-
quences are as follows: Tsc2/sh1 (5-GGTGAAGAGAGCCG
TATCACA-3), Tsc2/sh2 (5-GGTGTCATATGAGATTGT
TCT-3), and Tsc2/sh3 (5-GCACGGAGCACCAGTCTTAAT-
3). Tsc2/sh1 was adapted from a published sequence (Tavazoie
et al. 2005). Lentiviral shRNA constructs against SAD-A and
SAD-B were purchased from Sigma.
Antibodies and inhibitors
The following antibodies and inhibitors were used: anti-Akt,
anti-phospho-Akt (S473), anti-phospho-Tsc2 (T1462), anti-Tsc1,
anti-phospho-S6K (T389), anti-phospho-S6 (S235/236; Cell Sig-
naling); anti-Tau1, anti-MAP2 (Chemicon); anti--Actin
(Sigma); anti-Tsc2 (Upstate); anti--Tubulin (Santa Cruz); anti-
Tuj1, SMI-31, SMI-312 (Covance); anti-phospho-Tau (S262; In-
vitrogen); anti-MAP-2 (Santa Cruz); Alexa 350-conjugated goat
anti-mouse/rabbit, Alexa 568-conjugated goat anti-mouse/rab-
bit, Alexa 488-conjugated goat anti-mouse/rabbit (Invitrogen);
LY294002 (PI-3 kinase inhibitor), Rapamycin (mTOR inhibitor),
MG-132 (proteasome inhibitor) (Calbiochem). Anti-SAD-A,
anti-SAD-B, and anti-Phospho-SAD(T-al) antibodies were kind-
ly provided by J. Sanes (Kishi et al. 2005; Barnes et al. 2007).
Immunocytochemistry and immunohistochemistry
Neurons were fixed with 4% paraformaldehyde for 10 min and
washed with PBS. Fixed neurons were permeablized and
blocked with a solution containing 3% goat serum, 3% BSA,
and 0.1% Triton X-100 in PBS. Neurons were incubated with
primary antibody overnight at 4°C. After washing with PBS,
cells were stained with secondary antibodies at room tempera-
ture for 1 h and mounted with anti-fading agent (Aqua-poly
mount; Polysciences). Mice were anesthetized and perfused
with PBS, followed by 4% paraformaldehyde in PBS. Fixed
brains were then cryoprotected in 30% sucrose in PBS. Coronal
sections (50 µm) were cut using a Microm K400 Fast Freezing
Unit and HM450 Sliding Electronic Microtome and stored in
PBS at 4°C until use. Cortical sections were blocked in PBS
containing 4% goat serum and 0.1% Triton X-100 for 2 h and
were incubated with primary antibodies in blocking solution
overnight at 4°C. After wash, floating sections were incubated
with secondary antibodies and mounted with Aqua-poly mount
(Polysciences). Surgical resection specimens were fixed in 4%
paraformaldehyde, and 16-µm serial sections were prepared us-
ing a cryostat. Sections were incubated overnight at 4°C with
antibodies. Monoclonal antibody against SAD-A (1:100), poly-
clonal antibody against phospho-S6 (1:300), monoclonal anti-
body against SMI-311 (1:100), monoclonal antibody against -
tubulin (1:500), and polyclonal antibody against MAP-2 (1:800)
were used. Subsequently, sections were stained with fluores-
cent-conjugated secondary antibodies. Negative controls were
taken at the same exposure. Work on human tissues was ap-
proved by the Committee on Clinical Investigation at Chil-
dren’s Hospital Boston.
Image analysis
Images were obtained with Hamamatsu ORCA-ER camera us-
ing IPLab software. Fluorescence intensities were measured us-
ing Metamorph software. Neuronal polarity phenotypes were
categorized into three groups (no axon, single axon, and mul-
tiple axons). An axon was defined as a neurite whose length is
three times longer than other neurites and is also immunoreac-
tive for axonal markers (Tau1 or SMI-312). Cells were then
scored in a blinded manner. Statistical analysis of neuronal po-
larity defects in neurons was carried out by ANOVA. To exam-
ine neuronal polarity of Syn-Cre;Tsc1flox/flox mice, a Z series of
cortical sections stained with SMI-31/phospho-S6 or SMI-312/
phospho-S6 was collected using a Zeiss LSM510 Confocal Scan-
ning Laser microscope, and a projection was generated using
LSM software.
Lentivirus generation and infection
Lentiviral supernatants were prepared by cotransfecting 293T
cells with each lentiviral vector and four packaging vectors (rev,
tat, gag/pol, vsv-g) using Trans-IT-293T transfection reagent
(Mirus Bio). After overnight incubation, medium was replaced
and the supernatants were collected 48–60 h after transfection.
Dissociated hippocampal neurons were plated on six-well plates
coated with poly-D-Lysine at a density of 1 × 106 cells/well of a
six-well plate. After 6 h, neurons were infected with lentiviral
supernatants overnight. Neurons were washed three times with
plating medium (Neurobasal medium supplemented with B27)
and incubated for another 5 d.
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RT–PCR
To prepare RNA, rat hippocampal neurons were lysed at 6DIV,
and RNAs were prepared using an RNeasy minikit (Qiagen)
according to the manufacturer’s protocol. First-strand synthesis
was carried out using M-MLV reverse transcriptase (Invitrogen),
and 1.5 µL from each reaction was used as a template for each
PCR reaction. The following primers were used for PCR: SAD-A
(5-TTGAAGCCAGAGAACCTGCT-3, 5-GCTTGACCTTCT
CCAGCAAC-3), Tsc2 (5-CTGGATGCTGTGGTCTGCTA-
3, 5-CACAGATGTGGGGGAGTTCT-3), and b-Actin (5-
AAGACCTCTATGCCAACACAG-3, 5-CTGCTTGCTGAT
CCACATCTG-3).
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